Latest news

Moderna Inc (NASDAQ:MRNA) has exercised its option to license Autolus Therapeutics plc’s (NASDAQ:AUTL) proprietary binders against an undisclosed immuno-oncology target for…

Autolus Therapeutics plc (NASDAQ:AUTL) has entered into an agreement with Bristol-Myers Squibb Co (NYSE:BMY). The agreement grants Bristol Myers Squibb access to incorporate Autolus’…

- Bristol Myers Squibb to receive access to Autolus’ RQR8 safety switch for use in cell therapy programs - - Autolus to receive an upfront payment, with potential for near term option exercise fees and development

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 2.13 percent increase over losses of $(0.47) per share from

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

  During Thursday, 849 stocks hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  On Friday =, 431 companies hit new 52-week lows.

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.